TRACS: Online Cognitive Behavioral Therapy for Rehabilitation After Cardiac Surgery

Sponsor
Karolinska Institutet (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05727865
Collaborator
Karolinska University Hospital (Other)
30
1
1
12
2.5

Study Details

Study Description

Brief Summary

The purpose of the present pilot study is to evaluate the feasibility and potential efficacy of a brief, internet-delivered CBT protocol provided early following cardiac surgery.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Online CBT following cardiac surgery
N/A

Detailed Description

Cardiac surgery is a major surgical procedure used to treat for example coronary artery disease (CAD). The intervention increases survival rates and reduces cardiac symptom burden in cardiac patients. However, cardiac surgery is associated with elevated symptoms of psychological distress, which are related to several negative outcomes, such as poorer health-related quality of life (QoL) and response to treatment. There is a clear need to develop a brief psychological intervention that can be provided early in the clinical course after cardiac surgery to reduce psychological distress.

The purpose of this pilot study is to evaluate the feasibility and potential efficacy of a brief, exposure-based internet-delivered CBT protocol provided early after cardiac surgery. This is an uncontrolled pilot study with a pretest-posttest design. The study will include 30 participants. Assessments will be conducted pre-treatment, post-treatment, one- and six months after treatment. The one-month follow-up is the primary endpoint.

The treatment lasts for five weeks and will be provided as an early intervention following cardiac surgery ≥ eight weeks to nine months before assessment. It will include psychoeducation, behavioral activation to address post-operative fatigue and depression, interoceptive exposure to reduce fear of cardiac-related symptoms and in-vivo exposure to reduce avoided situations, and activities to enhance physical activity and wellbeing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Online Cognitive Behavioral Therapy for Rehabilitation After Cardiac Surgery
Anticipated Study Start Date :
Feb 17, 2023
Anticipated Primary Completion Date :
Feb 17, 2024
Anticipated Study Completion Date :
Feb 17, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Online CBT following cardiac surgery

The treatment lasts for five weeks and will be provided as an early intervention following cardiac surgery ≥ eight weeks to nine months before assessment. The intervention is psychologist-guided (clinical psychologist and/or resident psychologist under supervision) and delivered via text-based interactive online treatment modules, where patients complete weekly homework assignments and have regular online contact with psychologists with training in CBT for cardiac disease.

Behavioral: Online CBT following cardiac surgery
It will include psychoeducation, behavioral activation to address post-operative fatigue and depression, interoceptive exposure to reduce fear of cardiac-related symptoms and in-vivo exposure to reduce avoided situations, and activities to enhance physical activity and wellbeing. Labeling (i.e., describing post-operative and/or cardiac-related symptoms, thoughts, and feelings) will be used continuously during treatment to enhance the effect of exposure and pain management

Outcome Measures

Primary Outcome Measures

  1. 12-Item Short-Form Health Survey [Baseline to 2 months]

    General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life

  2. Acceptability: Client satisfaction Questionnaire [Baseline to 5 weeks.]

    Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment.

  3. Percentage of enrolled participants who complete the treatment [Baseline to 5 weeks]

    Feasibility of the intervention components will be assessed by >60% assessed as treatment completers. Descriptive analysis will also provide number of messages and therapist time.

  4. Adverse events [Baseline to 5 weeks]

    Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively').

Secondary Outcome Measures

  1. 12-Item Short-Form Health Survey [Baseline to 5 weeks]

    General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life

  2. 12-Item Short-Form Health Survey [Baseline to 7 months]

    General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life

  3. Cardiac anxiety questionnaire [Baseline to 5 weeks]

    Measure of cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 72, with a greater score indicating elevated cardiac anxiety.

  4. Cardiac anxiety questionnaire [Baseline to 2 months]

    Measure of cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 72, with a greater score indicating elevated cardiac anxiety.

  5. Cardiac anxiety questionnaire [Baseline to 7 months]

    Measure of cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 72, with a greater score indicating elevated cardiac anxiety.

  6. Patient Health Questionnaire-9 [Baseline to 5 weeks]

    Measure of depression, score ranging 0 to 27 with a higher score indicating higher level of depression

  7. Patient Health Questionnaire-9 [Baseline to 2 months]

    Measure of depression, score ranging 0 to 27 with a higher score indicating higher level of depression

  8. Patient Health Questionnaire-9 [Baseline to 7 months]

    Measure of depression, score ranging 0 to 27 with a higher score indicating higher level of depression

  9. Generalized Anxiety Disorder 7-item [Baseline to 5 weeks]

    General anxiety, score ranging from 0-21, with a higher score indicating more anxiety and worry.

  10. Generalized Anxiety Disorder 7-item [Baseline to 2 months]

    General anxiety, score ranging from 0-21, with a higher score indicating more anxiety and worry.

  11. Generalized Anxiety Disorder 7-item [Baseline to 7 months]

    General anxiety, score ranging from 0-21, with a higher score indicating more anxiety and worry.

  12. Brief Pain Inventory Short Form [Baseline to 5 weeks]

    Measure of pain interference and severity, with a higher score indicating more pain.

  13. Brief Pain Inventory Short Form [Baseline to 2 months]

    Measure of pain interference and severity, with a higher score indicating more pain.

  14. Brief Pain Inventory Short Form [Baseline to 7 months]

    Measure of pain interference and severity, with a higher score indicating more pain.

  15. Multidimensional fatigue inventory [Baseline to 5 weeks]

    Measure of fatigue, with a higher score indicating more fatigue.

  16. Multidimensional fatigue inventory [Baseline to 2 months]

    Measure of fatigue, with a higher score indicating more fatigue.

  17. Multidimensional fatigue inventory [Baseline to 7 months]

    Measure of fatigue, with a higher score indicating more fatigue.

  18. Symptom checklist Severity and Frequency Scale (SCL, adapted to coronary artery disease) [Baseline to 5 weeks]

    Cardiac-related symptoms in two sub scales A) frequency: score ranging from 0-48, with higher score indicating higher frequency of symptoms, B) severity of experienced symptom: score ranging from 0- 48, with a higher score indicating more severe symptoms

  19. Symptom checklist Severity and Frequency Scale (SCL, adapted to coronary artery disease) [Baseline to 2 months]

    Cardiac-related symptoms in two sub scales A) frequency: score ranging from 0-48, with higher score indicating higher frequency of symptoms, B) severity of experienced symptom: score ranging from 0- 48, with a higher score indicating more severe symptoms

  20. Symptom checklist Severity and Frequency Scale (SCL, adapted to coronary artery disease) [Baseline to 7 months]

    Cardiac-related symptoms in two sub scales A) frequency: score ranging from 0-48, with higher score indicating higher frequency of symptoms, B) severity of experienced symptom: score ranging from 0- 48, with a higher score indicating more severe symptoms

  21. The Godin Leisure-time Exercise and International Physical Activity Questionnaire 1 item on inactivity [Baseline to weeks]

    evel of physical activity and inactivity: On the Godin leisure-time excercise: The participant rate numbers of time per week that they engage in physical activity. The numb ers are the categorized in to low, moderate, and high levels of physical activity. And from International Physical Activity Questionnaire we will use 1 item on inactivity

  22. The Godin Leisure-time Exercise and International Physical Activity Questionnaire 1 item on inactivity [Baseline to 2 months]

    evel of physical activity and inactivity: On the Godin leisure-time excercise: The participant rate numbers of time per week that they engage in physical activity. The numb ers are the categorized in to low, moderate, and high levels of physical activity. And from International Physical Activity Questionnaire we will use 1 item on inactivity

  23. The Godin Leisure-time Exercise and International Physical Activity Questionnaire 1 item on inactivity [Baseline to 7 months]

    evel of physical activity and inactivity: On the Godin leisure-time excercise: The participant rate numbers of time per week that they engage in physical activity. The numb ers are the categorized in to low, moderate, and high levels of physical activity. And from International Physical Activity Questionnaire we will use 1 item on inactivity

  24. University of Toronto Atrial fibrillation Severity Scale (AFSS) [Baseline to 5 weeks]

    3 item on cardiac-specific healthcare consumption. Scores ranges 0-15 with a higher score indicating more cardiac-related healthcare consumption.

  25. University of Toronto Atrial fibrillation Severity Scale (AFSS) [Baseline to 2 months]

    3 item on cardiac-specific healthcare consumption. Scores ranges 0-15 with a higher score indicating more cardiac-related healthcare consumption.

  26. University of Toronto Atrial fibrillation Severity Scale (AFSS) [Baseline to 7 months]

    3 item on cardiac-specific healthcare consumption. Scores ranges 0-15 with a higher score indicating more cardiac-related healthcare consumption.

Other Outcome Measures

  1. Adverse events [Baseline to 2 months]

    otential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively').

  2. Adverse events [Baseline to 7 months]

    Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively').

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (A) Cardiac surgery (i.e., CABG, heart valve repair/replacement, aortic repair or combined CABG and valve repair/replacement) ≥ eight weeks to nine months before assessment

  • (B) Age 18 years and above;

  • (C) Endorses postoperative psychological distress and/or interference with daily life

  • (D) On medical treatment for the cardiac condition according to clinical guidelines;

  • (E) Ability to read and write in Swedish

Exclusion Criteria:
  • (F) Prior cardiac surgery with ventricular assist device or heart transplant;

  • (G) Hospitalized or living in a care facility;

  • (H) Any medical restriction to be physical active;

  • (I) Severe medical illness i.e., terminal cancer ;

  • (J) Severe psychiatric disorder or risk of suicide;

  • (K) Alcohol dependency;

  • (L) Ongoing psychological treatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska Institutet Stockholm Sweden

Sponsors and Collaborators

  • Karolinska Institutet
  • Karolinska University Hospital

Investigators

  • Principal Investigator: Josefin Särnholm, PhD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Josefin Särnholm, PhD, Lic. Psychologist, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT05727865
Other Study ID Numbers:
  • TRACS-PILOT
First Posted:
Feb 14, 2023
Last Update Posted:
Feb 14, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 14, 2023